GL1X · GenesisL1 explorer

Research workbench

Human ppargamma ligand-binding domain in complex with indomethacin

Analyse Human ppargamma ligand-binding domain in complex with indomethacin in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3ADS
Type
protein
Length
513 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Peroxisome proliferator-activated receptor gamma
UniProt
P37231
Ligands
IMN
Pockets
10 · best druggability 0.81

Structure

x-ray diffraction · 2 distinct chains · 68% helix, 5% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APeroxisome proliferator-activated receptor gammaprotein26268% helix, 5% strandP37231
BPeroxisome proliferator-activated receptor gammaprotein25168% helix, 5% strandP37231

Ligands and binding sites

  • IMN · Indomethacin · ligand · 3 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

10 pockets found on a 1 Å grid, 7 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15800.810.8657IMN
25140.790.8655IMN
31110.580.8625empty
41160.550.8323empty
52100.520.7724empty

Interfaces

1 interface between chains.

  • A–B · 1004 Ų buried · 7 hydrogen bonds · protein-protein

Compared structures

  • 3ADS · Human PPARgamma ligand-binding domain in complex with indomethacin · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.